Evaluation of CMV/EBV-CMI in Haploid HSCT

Soochow University

Status: Enrolling

Conditions: Hematopoietic Stem Cell Transplantation; Epstein-Barr Virus Infections; Cytomegalovirus Infections

Treatments: Diagnostic Test: CMV/EBV-CMI

Study type: Observational

Funder types: Other

Identifiers

NCT06554197

CMV/EBV-CMI

Details and patient eligibility

About

The purpose of this prospective, open-label, Single Arm, single-center study is to evaluate the cytomegalovirus and Epstein-Barr virus specific immune reestablishment for patients with hemopathy undergoingin prophylaxis for cytomegalovirus in haploid hematopoietic stem cell transplantation(haplo-HSCT) .

Enrollment: 60 estimated patients

Sex: All

Ages: 16 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. All patients were diagnosed with hemopathy.
2. All patients should have the indication of Haploidentical hematopoietic stem cell transplant and receive the prophylaxis for cytomegalovirus.
3. All patients should sign an informed consent document indicating that they understand the purpose of and procedures required for the study and be willing to participate in the study.

Exclusion criteria

Patients with any conditions not suitable for the trial (investigators' decision).